当前蛋白身份：P00004
重新检索
差异标签只比较当前检索结果；所有PDB和assembly原始记录仍分别保留。
相关结构差异明细
一行代表一个 PDB 条目中的一个 biological assembly；同一蛋白的多个单体会分别列出。
| PDB 条目 | Assembly / 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与非聚合物 | 实验方法 | 实验环境 | 结构质量 |
|---|---|---|---|---|---|---|---|
| 1AKK SOLUTION STRUCTURE OF OXIDIZED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE 提交 1997-05-22 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7；293 K
|
分辨率未提供 |
| 1CRC CYTOCHROME C AT LOW IONIC STRENGTH 提交 1995-03-22 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 | X-RAY DIFFRACTION | mmCIF 未提供已读取条件 | 分辨率 2.08 Å |
| 1CRC CYTOCHROME C AT LOW IONIC STRENGTH 提交 1995-03-22 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
1–104（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 | X-RAY DIFFRACTION | mmCIF 未提供已读取条件 | 分辨率 2.08 Å |
| 1FI7 Solution structure of the imidazole complex of cytochrome C 提交 2000-08-03 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | IMD IMIDAZOLE × 1 HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 5.7；313 K；压力 1
NMR样品组成
6mM cytochrome c, 1.2M Imidazole | H2O
NMR样品组成
6mM cytochrome c, 1.2M Imidazole | D2O
|
分辨率未提供 |
| 1FI9 SOLUTION STRUCTURE OF THE IMIDAZOLE COMPLEX OF CYTOCHROME C 提交 2000-08-03 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | IMD IMIDAZOLE × 1 HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 5.7；313 K；压力 1
NMR样品组成
6mM cytochrome c, 1.2M imidazole | H2O
NMR样品组成
6mM cytochrome c, 1.2M imidazole | D2O
|
分辨率未提供 |
| 1GIW SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE 提交 1998-06-17 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7；293 K；离子强度（mmCIF原始值）100 mM PHOSPHATE；压力 1013
NMR样品组成
H2O
|
分辨率未提供 |
| 1HRC HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF HORSE HEART CYTOCHROME C 提交 1994-08-16 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 | X-RAY DIFFRACTION | mmCIF 未提供已读取条件 | 分辨率 1.90 Å |
| 1I5T SOLUTION STRUCTURE OF CYANOFERRICYTOCHROME C 提交 2001-02-28 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | CYN CYANIDE ION × 1 HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7；303 K
NMR样品组成
5mM cytochrome c,50mM potassium cyanide | 90% H2O/10% D2O
NMR样品组成
5mM cytochrome c, 50mM potassium cyanide | D2O
|
分辨率未提供 |
| 1LC1 Solution Structure Of Reduced Horse Heart Cytochrome c in 30% Acetonitrile Solution, NMR Minimized Average Structure 提交 2002-04-04 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7.2；298 K；离子强度（mmCIF原始值）50mM；压力 1
NMR样品组成
5mM FERROCYTOCHROME C 1H; 50mM PHOSPHATE BUFFER; 70% H2O, 30% CD3CN | 70% H2O, 30% CD3CN
|
分辨率未提供 |
| 1LC2 Solution Structure Of Reduced Horse Heart Cytochrome c in 30% Acetonitrile Solution, NMR 30 Structures 提交 2002-04-04 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7.2；298 K；离子强度（mmCIF原始值）50mM；压力 1
NMR样品组成
5mM FERROCYTOCHROME C 1H; 50mM PHOSPHATE BUFFER; 70% H2O, 30% CD3CN | 70% H2O, 30% CD3CN
|
分辨率未提供 |
| 1M60 Solution Structure of Zinc-substituted cytochrome c 提交 2002-07-11 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HES ZINC SUBSTITUTED HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 6.5；293 K；压力 1
NMR样品组成
5mM Zn-cytc | 90% H2O, 10% D2O; 90% D2O, 10% D2O
|
分辨率未提供 |
| 1OCD CYTOCHROME C (OXIDIZED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE 提交 1996-07-03 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 5.7；293 K
NMR样品组成
[U-15N] 7-10 mM cytochrome c, 50 mM potassium phosphate | 90% H2O/10% D2O
NMR样品组成
[U-13C; U-15N] 15 mM cytochrome c, 50 mM potassium phosphate | 90% H2O/10% D2O
|
分辨率未提供 |
| 1U75 Electron Transfer Complex between Horse Heart Cytochrome c and Zinc-Porphyrin Substituted Cytochrome c Peroxidase 提交 2004-08-02 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 3 PDB 声明：trimeric（3） 与蛋白数一致 |
链 B
1–104（104 aa）
|
未记录 | PO4 PHOSPHATE ION × 2 ZNH PROTOPORPHYRIN IX CONTAINING ZN × 2 HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；MPD, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
分辨率 2.55 Å R-free 0.306 |
| 1WEJ IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION 提交 1998-03-26 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 3 PDB 声明：trimeric（3） 与蛋白数一致 |
链 F
1–104（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | ZN ZINC ION × 1 HEM PROTOPORPHYRIN IX CONTAINING FE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.4；50MM ZINC ACETATE BUFFER, PH 6.4, 25% (W/V) PEG 4000.
|
分辨率 1.80 Å R-free 0.256 |
| 1WEJ IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION 提交 1998-03-26 | Assembly 2 蛋白异源复合物 异源复合物；蛋白 × 3 PDB 声明：trimeric（3） 与蛋白数一致 |
链 F
1–104（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | ZN ZINC ION × 1 HEM PROTOPORPHYRIN IX CONTAINING FE × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
pH 6.4；50MM ZINC ACETATE BUFFER, PH 6.4, 25% (W/V) PEG 4000.
|
分辨率 1.80 Å R-free 0.256 |
| 2FRC CYTOCHROME C (REDUCED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE 提交 1996-07-02 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 5.7；293 K
|
分辨率未提供 |
| 2GIW SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, 40 STRUCTURES 提交 1998-06-25 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
1–104（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7；293 K；离子强度（mmCIF原始值）100 mM PHOSPHATE；压力 1013
NMR样品组成
H2O
|
分辨率未提供 |
| 2N3B Structure of oxidized horse heart cytochrome c encapsulated in reverse micelles 提交 2015-05-27 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
未记录 | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 7.4；298 K；压力 ambient
NMR样品组成
0.15 mM [U-100% 13C; U-100% 15N] protein, 1.5 M H2O, 25 mM sodium phosphate, 105 mM 1-decanoyl-rac-glycerol, 45 mM lauryldimethylamine-N-oxide, 8 mM hexanol, 8.67 M [U-99% 2H] pentane, Deuterated pentane | Deuterated pentane
NMR样品组成
0.15 mM [U-100% 15N] protein, 1.5 M H2O, 25 mM sodium phosphate, 105 mM 1-decanoyl-rac-glycerol, 45 mM lauryldimethylamine-N-oxide, 8 mM hexanol, 8.67 M [U-99% 2H] pentane, Deuterated pentane | Deuterated pentane
|
分辨率未提供 |
| 2PCB CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ELECTRON TRANSFER PARTNERS, CYTOCHROME C PEROXIDASE AND CYTOCHROME C 提交 1993-04-14 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 B
1–104（104 aa）
|
未记录 | HEM PROTOPORPHYRIN IX CONTAINING FE × 2 | X-RAY DIFFRACTION | mmCIF 未提供已读取条件 | 分辨率 2.80 Å |
| 3JBT Atomic structure of the Apaf-1 apoptosome 提交 2015-10-15 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 14 PDB 声明：tetradecameric（14） 与蛋白数一致 |
链 B
1–105（105 aa）
链 D
1–105（105 aa）
链 F
1–105（105 aa）
链 H
1–105（105 aa）
链 J
1–105（105 aa）
链 L
1–105（105 aa）
链 N
1–105（105 aa）
|
未记录 | DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 7 MG MAGNESIUM ION × 7 HEM PROTOPORPHYRIN IX CONTAINING FE × 7 | ELECTRON MICROSCOPY |
cryo-EM缓冲液
20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT；pH 7.5；20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT
cryo-EM玻璃化条件
Blot for 2.5 seconds before plunging；冷冻剂 ETHANE
|
分辨率 3.80 Å |
| 3NBS Crystal structure of dimeric cytochrome c from horse heart 提交 2010-06-04 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
2–105（104 aa）
链 B
2–105（104 aa）
|
未记录 | HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8.5；277 K；30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 2.20 Å R-free 0.273 |
| 3NBS Crystal structure of dimeric cytochrome c from horse heart 提交 2010-06-04 | Assembly 2 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 C
2–105（104 aa）
链 D
2–105（104 aa）
|
未记录 | HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 PO4 PHOSPHATE ION × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8.5；277 K；30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 2.20 Å R-free 0.273 |
| 3NBT Crystal structure of trimeric cytochrome c from horse heart 提交 2010-06-04 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 3 PDB 声明：trimeric（3） 与蛋白数一致 |
链 A
2–105（104 aa）
链 E
2–105（104 aa）
链 F
2–105（104 aa）
|
未记录 | HEC HEME C × 3 PG4 TETRAETHYLENE GLYCOL × 3 PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8.5；277 K；30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 2.10 Å R-free 0.254 |
| 3NBT Crystal structure of trimeric cytochrome c from horse heart 提交 2010-06-04 | Assembly 2 蛋白同源多聚体 同源多聚体；蛋白 × 3 PDB 声明：trimeric（3） 与蛋白数一致 |
链 B
2–105（104 aa）
链 C
2–105（104 aa）
链 D
2–105（104 aa）
|
未记录 | HEC HEME C × 3 PG4 TETRAETHYLENE GLYCOL × 3 PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8.5；277 K；30% PEG 200, 0.1M Tris-HCl, 0.2M ammonium phosphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 2.10 Å R-free 0.254 |
| 3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface 提交 2010-07-22 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 8 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.75 Å R-free 0.248 |
| 3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface 提交 2010-07-22 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 8 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.75 Å R-free 0.248 |
| 3O1Y Electron transfer complexes: Experimental mapping of the redox-dependent cytochrome c electrostatic surface 提交 2010-07-22 | Assembly 3 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 C
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 6 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；High concentration of NaNO3 and 10% Ditionite in the wells, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.75 Å R-free 0.248 |
| 3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface 提交 2010-07-22 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 7 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.90 Å R-free 0.276 |
| 3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface 提交 2010-07-22 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 8 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.90 Å R-free 0.276 |
| 3O20 Electron transfer complexes:experimental mapping of the Redox-dependent Cytochrome C electrostatic surface 提交 2010-07-22 | Assembly 3 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 C
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 NO3 NITRATE ION × 3 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7.4；300 K；Excess of NaNO3 and 10% of Ditionite, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.90 Å R-free 0.276 |
| 3WC8 Dimeric horse cytochrome c obtained by refolding with desalting method 提交 2013-05-25 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
2–105（104 aa）
|
未记录 | HEC HEME C × 2 PO4 PHOSPHATE ION × 2 PG4 TETRAETHYLENE GLYCOL × 2 PEG DI(HYDROXYETHYL)ETHER × 6 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8；277 K；100mM Tris-HCl buffer, 200mM (NH4)2HPO4, 40%(v/v) PEG200, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 1.80 Å R-free 0.208 |
| 3WUI Dimeric horse cytochrome c formed by refolding from molten globule state 提交 2014-04-25 | Assembly 1 蛋白同源多聚体 同源多聚体；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 A
2–105（104 aa）
|
未记录 | HEC HEME C × 2 PG4 TETRAETHYLENE GLYCOL × 2 PO4 PHOSPHATE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 4 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 8；277 K；100mM Tris-HCl buffer, 200mM (NH4)2HPO4, 40%(v/v) PEG 200, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
分辨率 1.80 Å R-free 0.227 |
| 4NFG K13R mutant of horse cytochrome c and yeast cytochrome c peroxidase complex 提交 2013-10-31 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 B
2–105（104 aa）
|
突变：K13R | HEM PROTOPORPHYRIN IX CONTAINING FE × 1 UNX UNKNOWN LIGAND × 1 HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；15% PEG 3350, 150 mM NaCl, 0.5 mM 1:1 ratio of horse cytochrome c and yeast cytochrome c peroxidase, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
分辨率 2.11 Å R-free 0.236 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
未记录 | HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 B
2–105（104 aa）
|
未记录 | HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 3 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 3 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 C
2–105（104 aa）
|
未记录 | HEC HEME C × 1 NO3 NITRATE ION × 4 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 4 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 D
2–105（104 aa）
|
未记录 | HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 5 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 E
2–105（104 aa）
|
未记录 | HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 3 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 6 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 F
2–105（104 aa）
|
未记录 | HEC HEME C × 1 CPT Cisplatin × 1 NO3 NITRATE ION × 2 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 4RSZ The X-ray structure of the Primary Adduct formed in the Reaction between Cisplatin and Cytochrome c 提交 2014-11-12 | Assembly 7 蛋白同源多聚体 同源多聚体；蛋白 × 6 PDB 声明：hexameric（6） 与蛋白数一致 |
链 A
2–105（104 aa）
链 B
2–105（104 aa）
链 C
2–105（104 aa）
链 D
2–105（104 aa）
链 E
2–105（104 aa）
链 F
2–105（104 aa）
|
未记录 | HEC HEME C × 6 CPT Cisplatin × 5 NO3 NITRATE ION × 16 SO4 SULFATE ION × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 7；300 K；A new crystal form of horse heart cytochrome c that co-crystallized with nitrate and sulphate ions has been obtained. Crystallization was prepared by using the hanging-drop vapour diffusion method in Linbro plates and a reservoir contained 3.5 M ammonium sulphate, 0.6 M sodium nitrate. The droplets consisted of 1 microliter protein (30 mg/mL in water) and 1 microliter of reservoir. They were equilibrated against a 500 microliters reservoir solution at 20 C. These conditions produced well shaped red crystals after 1 month. These crystals have been soaked for 24 h in a solution consisting of 0.005 M cisplatin in 2.0 M ammonium sulphate and 0.4 M sodium nitrate. To prepare this solution, Cisplatin was first dissolved in 5 mM sodium acetate buffer at pH 5.0. , VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.19 Å R-free 0.282 |
| 5IY5 Electron transfer complex of cytochrome c and cytochrome c oxidase at 2.0 angstrom resolution 提交 2016-03-24 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 14 PDB 声明：tetradecameric（14） 与蛋白数一致 |
链 1
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | CU COPPER (II) ION × 1 MG MAGNESIUM ION × 1 NA SODIUM ION × 2 HEA HEME-A × 2 PER PEROXIDE ION × 1 PGV (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE × 4 TGL TRISTEAROYLGLYCEROL × 3 CUA DINUCLEAR COPPER ION × 1 EDO 1,2-ETHANEDIOL × 6 CHD CHOLIC ACID × 4 PEK (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE × 1 CDL CARDIOLIPIN × 2 UNL UNKNOWN LIGAND × 5 PSC (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE × 1 ZN ZINC ION × 1 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1 HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
BATCH MODE；pH 8；277 K；15mM sodium phosphate, pH 8.0, 0.7% fluorinated octylmaltoside, 0.2% decylmaltoside, 3% ethylene glycol, 5% PEG 4000
|
分辨率 2.00 Å R-free 0.207 |
| 5IY5 Electron transfer complex of cytochrome c and cytochrome c oxidase at 2.0 angstrom resolution 提交 2016-03-24 | Assembly 2 蛋白异源复合物 异源复合物；蛋白 × 14 PDB 声明：tetradecameric（14） 与蛋白数一致 |
链 2
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | CU COPPER (II) ION × 1 MG MAGNESIUM ION × 1 NA SODIUM ION × 2 HEA HEME-A × 2 PER PEROXIDE ION × 1 PGV (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE × 3 TGL TRISTEAROYLGLYCEROL × 2 CUA DINUCLEAR COPPER ION × 1 EDO 1,2-ETHANEDIOL × 3 CHD CHOLIC ACID × 4 PEK (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE × 1 CDL CARDIOLIPIN × 2 UNL UNKNOWN LIGAND × 10 PSC (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE × 1 ZN ZINC ION × 1 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1 HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
BATCH MODE；pH 8；277 K；15mM sodium phosphate, pH 8.0, 0.7% fluorinated octylmaltoside, 0.2% decylmaltoside, 3% ethylene glycol, 5% PEG 4000
|
分辨率 2.00 Å R-free 0.207 |
| 5WVE Apaf-1-Caspase-9 holoenzyme 提交 2016-12-24 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 25 PDB 声明：25-meric（25） 与蛋白数一致 |
链 B
1–105（105 aa）
链 D
1–105（105 aa）
链 F
1–105（105 aa）
链 H
1–105（105 aa）
链 J
1–105（105 aa）
链 L
1–105（105 aa）
链 N
1–105（105 aa）
|
未记录 | DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 7 MG MAGNESIUM ION × 7 HEM PROTOPORPHYRIN IX CONTAINING FE × 7 | ELECTRON MICROSCOPY |
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 4.40 Å |
| 5ZKV Solution structure of molten globule state of L94G mutant of horse cytochrome-c 提交 2018-03-26 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
突变：L94G | HEC HEME C × 1 | SOLUTION NMR |
NMR测量条件
pH 6；298 K；离子强度（mmCIF原始值）0.03 M cacodylate buffer containing 0.1 M NaCl；压力 1
NMR样品组成
2 mM [U-99% 13C; U-99% 15N] Molten globule of L94G mutant of horse cytochrome-c, 90% H2O/10% D2O | 90% H2O/10% D2O
|
分辨率未提供 |
| 6K9I High-resolution three-dimensional structure of horse heart cytochrome C at room temperature 提交 2019-06-16 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 6.4；293 K；1.0-1.5M sodium chloride, 2.7-3.2M ammonium sulfate, 0.1M sodium phosphate
|
分辨率 1.80 Å R-free 0.199 |
| 6K9J 0.98 A three-dimensional structure of horse heart cytochrome C at 110K 提交 2019-06-16 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 A
2–105（104 aa）
|
非标准单体：是（mmCIF未提供具体位点） | HEC HEME C × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；pH 6.4；293 K；1.0-1.5M sodium chloride, 2.7-3.2M ammonium sulfate, 0.1M sodium phosphate
|
分辨率 0.98 Å R-free 0.153 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 1 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 AaA
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 2 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 BaB
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 3 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 CaC
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 4 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 DaD
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 5 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 EaE
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 6 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 FaF
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 7 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 GaG
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 6SUV Horse cytochrome c complexed by octa-anionic calixarene 提交 2019-09-16 | Assembly 8 蛋白单体 单体；蛋白 × 1 PDB 声明：monomeric（1） 与蛋白数一致 |
链 HaH
2–105（104 aa）
|
未记录 | ACE ACETYL GROUP × 1 HEC HEME C × 1 LVQ octa-anionic calixarene × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP；pH 5.5；293 K；56% PEG 3350, 0.05 M sodium cacodylate pH 5.5 and 0.0017 M gadolinium chloride
|
分辨率 2.50 Å R-free 0.237 |
| 8ZXR Crystal structure of Ssr1698 in complex with heme c 提交 2024-06-14 | Assembly 1 蛋白异源复合物 异源复合物；蛋白 × 2 PDB 声明：dimeric（2） 与蛋白数一致 |
链 B
12–22（11 aa）
|
未记录 | NI NICKEL (II) ION × 1 CL CHLORIDE ION × 2 HEC HEME C × 1 GOL GLYCEROL × 1 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；289 K；Sodium acetate, Sodium formate, Glycerol
|
分辨率 1.60 Å R-free 0.218 |
| 8ZXR Crystal structure of Ssr1698 in complex with heme c 提交 2024-06-14 | Assembly 2 蛋白异源复合物 异源复合物；蛋白 × 12 PDB 声明：dodecameric（12） 与蛋白数一致 |
链 B
12–22（11 aa）
|
未记录 | NI NICKEL (II) ION × 6 CL CHLORIDE ION × 12 HEC HEME C × 6 GOL GLYCEROL × 6 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；289 K；Sodium acetate, Sodium formate, Glycerol
|
分辨率 1.60 Å R-free 0.218 |
| 8ZXR Crystal structure of Ssr1698 in complex with heme c 提交 2024-06-14 | Assembly 3 蛋白异源复合物 异源复合物；蛋白 × 6 PDB 声明：hexameric（6） 与蛋白数一致 |
链 B
12–22（11 aa）
|
未记录 | NI NICKEL (II) ION × 3 CL CHLORIDE ION × 6 HEC HEME C × 3 GOL GLYCEROL × 3 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；289 K；Sodium acetate, Sodium formate, Glycerol
|
分辨率 1.60 Å R-free 0.218 |
| 8ZXR Crystal structure of Ssr1698 in complex with heme c 提交 2024-06-14 | Assembly 4 蛋白异源复合物 异源复合物；蛋白 × 4 PDB 声明：tetrameric（4） 与蛋白数一致 |
链 B
12–22（11 aa）
|
未记录 | NI NICKEL (II) ION × 2 CL CHLORIDE ION × 4 HEC HEME C × 2 GOL GLYCEROL × 2 | X-RAY DIFFRACTION |
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP；289 K；Sodium acetate, Sodium formate, Glycerol
|
分辨率 1.60 Å R-free 0.218 |